Literature DB >> 26982264

Claudin 1 Expression Levels Affect miRNA Dynamics in Human Basal-Like Breast Cancer Cells.

Anna Majer1,2, Anne A Blanchard3,4, Sarah Medina2, Stephanie A Booth1,2, Yvonne Myal3,4.   

Abstract

Deemed a putative tumor suppressor in breast cancer, the tight junction protein claudin 1 has now been shown to be highly expressed in the basal-like molecular subtype. Moreover, recent in vitro studies show that claudin 1 can regulate breast cancer cell motility and proliferation. Herein, we investigated whether microRNA (miRNA) dysregulation is associated with alterations in the level of claudin 1. Using next-generation sequencing (NGS), we identified seven miRNAs (miR-9-5p, miR-9-3p, let-7c, miR-127-3p, miR-99a-5p, miR-129-5p, and miR-146a-5p) that were deregulated as a consequence of claudin 1 overexpression in the MDA-MB231 human breast cancer (HBC) cell line. Most of these miRNAs have been associated with tumor suppression in a variety of cancers, including breast cancer. Moreover, through gene expression profiling analysis, we identified epithelial-mesenchymal transition-related genes, including platelet-derived growth factor receptor-beta (PDGFRB) and cadherin 1 (CDH1, E cadherin), whose downregulation correlated with claudin 1 overexpression. Collectively, we show for the first time that in HBC, claudin 1 can alter the dynamics of a number of miRNAs involved in tumor progression. Our data suggest that the dysregulated expression of these miRNAs, in conjunction with the high claudin 1 levels, could serve as a useful biomarker that identifies a subset of tumors within the poorly characterized basal-like subtype of breast cancer. Further studies are warranted to determine the role of these miRNAs in facilitating the function of claudin 1 in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26982264     DOI: 10.1089/dna.2015.3188

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  6 in total

1.  Comparison of Fixation Methods for the Detection of Claudin 1 and E-Cadherin in Breast Cancer Cell Lines by Immunofluorescence.

Authors:  Chidalu A Edechi; Maryam Amini; Mohammad K Hamedani; Lucas E L Terceiro; Barbara E Nickel; Etienne Leygue; Yvonne Myal
Journal:  J Histochem Cytochem       Date:  2021-10-29       Impact factor: 2.479

2.  Expression of Claudin-1 in laryngeal squamous cell carcinomas (LSCCs) and its significance.

Authors:  Abderrahman Ouban
Journal:  Histol Histopathol       Date:  2021-02-25       Impact factor: 2.303

3.  Overexpressed somatic alleles are enriched in functional elements in Breast Cancer.

Authors:  Paula Restrepo; Mercedeh Movassagh; Nawaf Alomran; Christian Miller; Muzi Li; Chris Trenkov; Yulian Manchev; Sonali Bahl; Stephanie Warnken; Liam Spurr; Tatiyana Apanasovich; Keith Crandall; Nathan Edwards; Anelia Horvath
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

4.  Expression of miR-146a-5p in breast cancer and its role in proliferation of breast cancer cells.

Authors:  Wei Gao; Jing Hua; Zhaoyang Jia; Jiping Ding; Zengwei Han; Yun Dong; Qing Lin; Yuan Yao
Journal:  Oncol Lett       Date:  2018-04-26       Impact factor: 2.967

Review 5.  Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk.

Authors:  Ajaz A Bhat; Srijayaprakash Uppada; Iman W Achkar; Sheema Hashem; Santosh K Yadav; Muralitharan Shanmugakonar; Hamda A Al-Naemi; Mohammad Haris; Shahab Uddin
Journal:  Front Physiol       Date:  2019-01-23       Impact factor: 4.566

6.  Glucose-limiting conditions induce an invasive population of MDA-MB-231 breast cancer cells with increased connexin 43 expression and membrane localization.

Authors:  Jennifer C Jones; Amanda M Miceli; Mary M Chaudhry; Chloe S Kaunitz; Mallika A Jai; Romel N Pancho; Alan Lazzar; Bradley S Taylor; Vishnupriya Bodempudi; Prarthana P Jain; Sheeri Hanjra; Alexander E Urban; Brian Zanotti; Ellen K Kohlmeir; Thomas M Bodenstine
Journal:  J Cell Commun Signal       Date:  2021-02-16       Impact factor: 5.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.